Junaid Anwar, MD, discusses a meta-analysis of five landmark trials evaluating Janus kinase inhibitors for myelofibrosis, highlighting first-line efficacy and tolerability with ruxolitinib, second-line...
In this video, Paolo Strati, MD, discusses chemotherapy-free approaches in the treatment of patients with indolent b-cell lymphoma, including early trials that are underway on the combination of...
